Literature DB >> 33569629

Neuron-specific activation of necroptosis signaling in multiple sclerosis cortical grey matter.

Carmen Picon1, Anusha Jayaraman2, Rachel James1, Catriona Beck1, Patricia Gallego1, Maarten E Witte3, Jack van Horssen3,4, Nicholas D Mazarakis1, Richard Reynolds5,6.   

Abstract

Sustained exposure to pro-inflammatory cytokines in the leptomeninges is thought to play a major role in the pathogenetic mechanisms leading to cortical pathology in multiple sclerosis (MS). Although the molecular mechanisms underlying neurodegeneration in the grey matter remain unclear, several lines of evidence suggest a prominent role for tumour necrosis factor (TNF). Using cortical grey matter tissue blocks from post-mortem brains from 28 secondary progressive MS subjects and ten non-neurological controls, we describe an increase in expression of multiple steps in the TNF/TNF receptor 1 signaling pathway leading to necroptosis, including the key proteins TNFR1, FADD, RIPK1, RIPK3 and MLKL. Activation of this pathway was indicated by the phosphorylation of RIPK3 and MLKL and the formation of protein oligomers characteristic of necrosomes. In contrast, caspase-8 dependent apoptotic signaling was decreased. Upregulation of necroptotic signaling occurred predominantly in macroneurons in cortical layers II-III, with little expression in other cell types. The presence of activated necroptotic proteins in neurons was increased in MS cases with prominent meningeal inflammation, with a 30-fold increase in phosphoMLKL+ neurons in layers I-III. The density of phosphoMLKL+ neurons correlated inversely with age at death, age at progression and disease duration. In vivo induction of chronically elevated TNF and INFγ levels in the CSF in a rat model via lentiviral transduction in the meninges, triggered inflammation and neurodegeneration in the underlying cortical grey matter that was associated with increased neuronal expression of TNFR1 and activated necroptotic signaling proteins. Exposure of cultured primary rat cortical neurons to TNF induced necroptosis when apoptosis was inhibited. Our data suggest that neurons in the MS cortex are dying via TNF/TNFR1 stimulated necroptosis rather than apoptosis, possibly initiated in part by chronic meningeal inflammation. Neuronal necroptosis represents a pathogenetic mechanism that is amenable to therapeutic intervention at several points in the signaling pathway.

Entities:  

Keywords:  Apoptosis; Cytokines; Meninges; Necroptosis; Neurodegeneration

Year:  2021        PMID: 33569629      PMCID: PMC7952371          DOI: 10.1007/s00401-021-02274-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  66 in total

1.  Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats.

Authors:  Christopher Gardner; Roberta Magliozzi; Pascal F Durrenberger; Owain W Howell; Jon Rundle; Richard Reynolds
Journal:  Brain       Date:  2013-10-30       Impact factor: 13.501

2.  Necroptosis drives motor neuron death in models of both sporadic and familial ALS.

Authors:  Diane B Re; Virginia Le Verche; Changhao Yu; Mackenzie W Amoroso; Kristin A Politi; Sudarshan Phani; Burcin Ikiz; Lucas Hoffmann; Martijn Koolen; Tetsuya Nagata; Dimitra Papadimitriou; Peter Nagy; Hiroshi Mitsumoto; Shingo Kariya; Hynek Wichterle; Christopher E Henderson; Serge Przedborski
Journal:  Neuron       Date:  2014-02-06       Impact factor: 17.173

3.  Inflammatory intrathecal profiles and cortical damage in multiple sclerosis.

Authors:  Roberta Magliozzi; Owain W Howell; Richard Nicholas; Carolina Cruciani; Marco Castellaro; Chiara Romualdi; Stefania Rossi; Marco Pitteri; Maria Donata Benedetti; Alberto Gajofatto; Francesca B Pizzini; Stefania Montemezzi; Sarah Rasia; Ruggero Capra; Alessandra Bertoldo; Francesco Facchiano; Salvatore Monaco; Richard Reynolds; Massimiliano Calabrese
Journal:  Ann Neurol       Date:  2018-04       Impact factor: 10.422

4.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

Authors:  J W Peterson; L Bö; S Mörk; A Chang; B D Trapp
Journal:  Ann Neurol       Date:  2001-09       Impact factor: 10.422

Review 5.  Exploring the origins of grey matter damage in multiple sclerosis.

Authors:  Massimiliano Calabrese; Roberta Magliozzi; Olga Ciccarelli; Jeroen J G Geurts; Richard Reynolds; Roland Martin
Journal:  Nat Rev Neurosci       Date:  2015-03       Impact factor: 34.870

6.  The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease.

Authors:  Maritza Oñate; Alejandra Catenaccio; Natalia Salvadores; Cristian Saquel; Alexis Martinez; Ines Moreno-Gonzalez; Nazaret Gamez; Paulina Soto; Claudio Soto; Claudio Hetz; Felipe A Court
Journal:  Cell Death Differ       Date:  2019-10-07       Impact factor: 15.828

Review 7.  The neuropathological basis of clinical progression in multiple sclerosis.

Authors:  Richard Reynolds; Federico Roncaroli; Richard Nicholas; Bishan Radotra; Djordje Gveric; Owain Howell
Journal:  Acta Neuropathol       Date:  2011-05-28       Impact factor: 17.088

8.  Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis.

Authors:  Owain W Howell; Jon L Rundle; Anurag Garg; Masayuki Komada; Peter J Brophy; Richard Reynolds
Journal:  J Neuropathol Exp Neurol       Date:  2010-10       Impact factor: 3.685

9.  The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain.

Authors:  Lukas Haider; Tobias Zrzavy; Simon Hametner; Romana Höftberger; Francesca Bagnato; Günther Grabner; Siegfried Trattnig; Sabine Pfeifenbring; Wolfgang Brück; Hans Lassmann
Journal:  Brain       Date:  2016-02-08       Impact factor: 13.501

10.  Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target.

Authors:  Lauren Mifflin; Dimitry Ofengeim; Junying Yuan
Journal:  Nat Rev Drug Discov       Date:  2020-07-15       Impact factor: 112.288

View more
  13 in total

1.  CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis.

Authors:  Damiano Marastoni; Anna I Pisani; Gianmarco Schiavi; Valentina Mazziotti; Marco Castellaro; Agnese Tamanti; Francesca Bosello; Francesco Crescenzo; Giuseppe K Ricciardi; Stefania Montemezzi; Francesca B Pizzini; Massimiliano Calabrese
Journal:  Ther Adv Neurol Disord       Date:  2022-06-21       Impact factor: 6.430

Review 2.  Cell death in development, maintenance, and diseases of the nervous system.

Authors:  Sourav Ghosh; Carla V Rothlin; Maria E Mercau; Siraj Patwa; Krishna P L Bhat
Journal:  Semin Immunopathol       Date:  2022-05-04       Impact factor: 11.759

Review 3.  The role of necroptosis in disease and treatment.

Authors:  Xiaoxiao Liu; Xin Xie; Yuanyuan Ren; Zhiying Shao; Nie Zhang; Liantao Li; Xin Ding; Longzhen Zhang
Journal:  MedComm (2020)       Date:  2021-12-20

4.  TNF-mediated neuroinflammation is linked to neuronal necroptosis in Alzheimer's disease hippocampus.

Authors:  Anusha Jayaraman; Thein Than Htike; Rachel James; Carmen Picon; Richard Reynolds
Journal:  Acta Neuropathol Commun       Date:  2021-09-28       Impact factor: 7.801

Review 5.  Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics.

Authors:  Emily Kamma; Wendy Lasisi; Cole Libner; Huah Shin Ng; Jason R Plemel
Journal:  J Neuroinflammation       Date:  2022-02-10       Impact factor: 8.322

6.  Protective Effect of GIP against Monosodium Glutamate-Induced Ferroptosis in Mouse Hippocampal HT-22 Cells through the MAPK Signaling Pathway.

Authors:  Jiwon Ko; Soyoung Jang; Wookbong Kwon; Si-Yong Kim; Soyeon Jang; Eungyung Kim; Young-Rae Ji; Sijun Park; Myoung-Ok Kim; Seong-Kyoon Choi; Dong-Hyung Cho; Hyun-Shik Lee; Su-Geun Lim; Zae-Young Ryoo
Journal:  Antioxidants (Basel)       Date:  2022-01-19

7.  Inhibition of RIPK1 by ZJU-37 promotes oligodendrocyte progenitor proliferation and remyelination via NF-κB pathway.

Authors:  Xiao-Ru Ma; Shu-Ying Yang; Shuang-Shuang Zheng; Huan-Huan Yan; Hui-Min Gu; Fan Wang; Yang Wu; Zhao-Jun Dong; Di-Xian Wang; Yue Wang; Xianhui Meng; Jie Sun; Hong-Guang Xia; Jing-Wei Zhao
Journal:  Cell Death Discov       Date:  2022-04-01

8.  A Systematic Review of Tissue and Single Cell Transcriptome/Proteome Studies of the Brain in Multiple Sclerosis.

Authors:  Maria L Elkjaer; Richard Röttger; Jan Baumbach; Zsolt Illes
Journal:  Front Immunol       Date:  2022-03-02       Impact factor: 7.561

Review 9.  The Possible Role of Neural Cell Apoptosis in Multiple Sclerosis.

Authors:  Peter G E Kennedy; Woro George; Xiaoli Yu
Journal:  Int J Mol Sci       Date:  2022-07-08       Impact factor: 6.208

Review 10.  Supramolecular organizing centers at the interface of inflammation and neurodegeneration.

Authors:  Petra Sušjan-Leite; Taja Železnik Ramuta; Elvira Boršić; Sara Orehek; Iva Hafner-Bratkovič
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.